Liposomal α-cyperone targeting bone resorption surfaces suppresses osteoclast differentiation and osteoporosis progression via the PI3K/Akt axis
- 31 October 2023
- journal article
- research article
- Published by Tsinghua University Press in Nano Research
- Vol. 17 (4) , 2949-2959
Abstract
Osteoporosis is a metabolic dysregulation of bone that occurs mainly in postmenopausal women, and the hyperfunction of osteoclasts is the primary contributor to postmenopausal osteoporosis. However, the development of effective therapeutic drugs and precise delivery systems remains a challenge in the field of anti-absorption therapy. Here, we reported the α-cyperone (α-CYP) for anti-osteoporosis and developed a liposome-based nano-drug delivery system of α-CYP, that specifically targets the bone resorption interface. Firstly, we found that the α-CYP, one of the major sesquiterpenes of Cyperus rotundus L., attenuated the progression of osteoporosis in ovariectomized (OVX) mice and down-regulated the expression of phosphorylated proteins of phosphoinositide 3-kinase (PI3K) and protein kinase B (Akt), causing down-regulation of osteoclast-related genes/proteins and curbing osteoclast differentiation. Furthermore, α-CYP reversed the activation of osteoclastic differentiation and enhanced osteoporosis-related proteins expression caused by PI3K/Akt agonist (YS-49). More importantly, we adopted the osteoclastic resorption surface targeting peptide Asp8 and constructed the liposome (lipaC@Asp8) to deliver α-CYP to osteoclasts and confirmed its anti-osteoporosis effect and enhanced osteoclast inhibition by blocking PI3K/Akt axis. In conclusion, this study demonstrated that α-CYP inhibits osteoclast differentiation and osteoporosis development by silencing PI3K/Akt pathway, and the liposome targeting delivery systems loaded with α-CYP might provide a novel and effective strategy to treat osteoporosis.Keywords
This publication has 38 references indexed in Scilit:
- RGD-modified pH-sensitive liposomes for docetaxel tumor targetingColloids and Surfaces B: Biointerfaces, 2015
- α-Cyperone, isolated from the rhizomes of Cyperus rotundus, inhibits LPS-induced COX-2 expression and PGE2 production through the negative regulation of NFκB signalling in RAW 264.7 cellsJournal of Ethnopharmacology, 2013
- Pathophysiology of OsteoporosisEndocrinology and Metabolism Clinics of North America, 2012
- A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapyNature Medicine, 2012
- Network pharmacology: the next paradigm in drug discoveryNature Chemical Biology, 2008
- Osteotropic Peptide That Differentiates Functional Domains of the SkeletonBioconjugate Chemistry, 2007
- Pharmacokinetic and Biodistribution Studies of a Bone-Targeting Drug Delivery System Based onN-(2-Hydroxypropyl)methacrylamide CopolymersMolecular Pharmaceutics, 2006
- Synthesis and Evaluation of Water-Soluble Polymeric Bone-Targeted Drug Delivery SystemsBioconjugate Chemistry, 2003
- Osteoclast differentiation and activationNature, 2003
- Pulmonary Delivery of Beclomethasone Liposome Aerosol in VolunteersChest, 1997